Posted on

What Caught Our Attention in the Investment World? – Week of January 3-6, 2023

By Kuldip K. Ambastha On Thursday, January 5, 2023, the stock of NovoCure Limited (NVCR), an oncology company, rose by +68.5% for the trading day. The LUNAR study has shown that a medical device developed by NovoCure is able to improve, in a statistically significant way, the prospect of survival for people with late-stage lung …

Continue reading “What Caught Our Attention in the Investment World? – Week of January 3-6, 2023”

Posted on

What Caught Our Attention in the Investment World? – Week of March 28-April 1, 2022

By Kuldip K. Ambastha Longeveron Inc. (LGVN), a biotechnology company focused on clinical stage therapies, had its stock price rise by +105.4% per share on Thursday, March 31, 2022. On this trading day, a great piece of news led to a great return. Lomecel-B has shown positive results from its Phase 1 trial testing on …

Continue reading “What Caught Our Attention in the Investment World? – Week of March 28-April 1, 2022”

Posted on

What Caught Our Attention in the Investment World? – Week of February 24-28, 2020

By Kuldip K. Ambastha and Anil K. Ambastha On Tuesday, February 25, 2020, the stock of Moderna, Inc. (MRNA) rose by 27.8% for the day. As the coronavirus (COVID-19) has spread around the world and led to a sell-off in the capital markets, Moderna, Inc. announced that its coronavirus vaccine candidate is scheduled to be …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 24-28, 2020”